Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
Novo Nordisk (NVO) reportedly plans to phase out production of its human insulin pens while it ramps up production of other ...
Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...
The global insulin pens market size was valued at USD 7.46 billion in 2024 and is projected to reach from USD 8.05 billion in ...
MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...
Novo Nordisk said Thursday that it plans to eventually halt all of its human insulin pen production globally, ...
Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...
Dr Vincent Simpson says the reusable pens reduce plastic waste and could save the NHS money.
This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...
This all-encompassing guide investigates the smart insulin pen and its influence on diabetes management. Here's what you need ...
Ahead of World Diabetes Day, Doctors Without Borders (MSF) called on pharmaceutical corporations Eli Lilly, Novo Nordisk, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback